Orna Therapeutics Welcomes Joseph Bolen, Ph.D. as New CEO to Lead Innovative Cancer and Autoimmune Treatments#United_States#Watertown#Orna_Therapeutics#Biotech_Innovation#Joseph_Bolen
Orna Therapeutics Welcomes Joseph Bolen, Ph.D. as New CEO to Lead Innovative Cancer and Autoimmune Treatments
Orna Therapeutics has appointed Joseph Bolen, Ph.D. as CEO to guide the company in its clinical trials for innovative RNA therapies targeting cancer and autoimmune diseases.
third-news.com
April 2, 2025 at 3:04 AM
Orna Therapeutics Welcomes Joseph Bolen, Ph.D. as New CEO to Lead Innovative Cancer and Autoimmune Treatments#United_States#Watertown#Orna_Therapeutics#Biotech_Innovation#Joseph_Bolen